TABLE 1

Prevalence of CYP2C9*2 and CYP2C9*3 alleles in the study population (individuals screened for genotype, before inclusion in the pharmacokinetic study)


SNPs

No. of Subjects (n = 187)a
Homozygous
Heterozygous
CYP2C9*2 2 23
CYP2C9*3
2
18
  • a CYP2C9*1*1 – n = 142